Application of nucleic acid sequence-based amplification in detection of cytomegalovirus mRNA of recipients after allogeneic peripheral blood stem cell transplantation.
- Author:
Hong-Xu XU
1
;
Ya-Feng LIU
;
En-Xun TAN
;
Jian-Tao CAI
Author Information
1. Laboratory of Transplantation Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China. xhx333@163.com
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Child;
Cytomegalovirus;
isolation & purification;
Cytomegalovirus Infections;
diagnosis;
virology;
Female;
Hematologic Neoplasms;
therapy;
Humans;
Male;
Peripheral Blood Stem Cell Transplantation;
adverse effects;
RNA, Viral;
analysis;
Self-Sustained Sequence Replication
- From:
Journal of Experimental Hematology
2006;14(6):1195-1199
- CountryChina
- Language:Chinese
-
Abstract:
The study was purposed to investigate diagnostic value of late-mRNA detection by nucleic acid sequence-based amplification (NASBA) technique for human cytomegalovirus (HCMV) infection of the recipients after allogeneic peripheral blood stem cell transplantation (allo-PBSCT) and to evaluate the clinical significance for guiding antiviral therapy. 352 samples were collected from 128 transplant patients after allo-PBSCT. A molecular biological diagnostic technique--NASBA was used to detect human cytomegalovirus (HCMV) late mRNA encoding the viral structural protein PP67 (UL65) expression in peripheral blood of recipients after allo-PBSCT, and the detected results were compared with HCMV DNA detection by PCR. The sensitivity, specificity and early diagnostic value of HCMV mRNA detection for HCMV disease were evaluated. The results showed that out of 352 detected blood specimens from 84 patients 183 specimens (51.99%) were positive of HCMV DNA by PCR, 105 specimens (29.83%) were positive of HCMV mRNA by NASBA. 45 patients were infected by HCMV. The sensitivity and specificity of HCMV DNA and HCMV mRNA for detecting HCMV disease were 95.56% (43/45), 93.33% (42/45) and 60.24% (50/83), 97.59% (81/83). The results of specificity showed significant difference between two groups of HCMV mRNA and HCMV DNA (P < 0.05). It is concluded that the detection of late-mRNA of HCMV by NASBA technique is rapid, sensitive and specific detection for HCMV active infection. The detected result correlates with clinical symptoms. It can monitor HCMV infection of allo-PBSCT transplanted recipients and provide indication to antiviral therapy.
